Research Article

Blood Transfusions in Total Hip and Knee Arthroplasty: An Analysis of Outcomes

Table 3

The incidence of complications, mortality, and resource utilization, characterized by transfusion usage.

ComplicationTransfusionNo transfusion value
(%) (%)

Combined major complications19,127 (19.06)48,214 (11.22)<0.001
Major cardiac complications8,721 (8.69)25,785 (6)<0.001
 Acute myocardial infarction719 (0.72)675 (0.16)<0.001
 Cardiac (Non-MI)8,441 (8.41)25,516 (5.94)<0.001
Major pulmonary complications3,274 (3.26)5,803 (1.35)<0.001
 Pulmonary embolism733 (0.73)1,442 (0.34)<0.001
 Pulmonary complications1,368 (1.36)2,143 (0.5)<0.001
 Pneumonia1,706 (1.7)2,872 (0.67)<0.001
Deep venous thrombosis958 (0.95)1,973 (0.46)<0.001
Cerebrovascular event222 (0.22)384 (0.09)<0.001
All infections7,063 (7.04)14,574 (3.39)<0.001
Acute renal failure3,488 (3.48)4,498 (1.05)<0.001
Gastrointestinal complication1,168 (1.16)2,910 (0.68)<0.001
Mortality (30 day)288 (0.29)513 (0.12)<0.001
Mechanical ventilation1,213 (1.21)2,592 (0.6)<0.001
Critical care services admission4,975 (4.96)12,385 (2.88)<0.001

MI: myocardial infarction.